See also this year's filing and all EDGAR filings for this company.
PDF Report 0000827871_2023_EAGLE_PHARMACEUTICALS_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000827871, EAGLE PHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 188,754,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 163,360,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,168,000 |
| 3 | remainder_Assets | 52,878,000 |
| 4 | LiabilitiesCurrent | 111,087,000 |
| 5 | LiabilitiesNoncurrent | 61,513,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 85,458,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 106,626,000 |
| 9 | ResearchAndDevelopmentExpense | 34,088,000 |
| 10 | remainder_Expenses | 35,269,000 |
| 11 | remainder_Revenues | 316,610,000 |
| 12 | remainder_NetIncome | -19,527,000 |
| 13 | remainder_ComprehensiveNetIncome | -1,018,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 406,160,000 |
| 1 | Liabilities | 172,600,000 |
| 2 | Expenses | 261,441,000 |
| 3 | Revenues | 316,610,000 |
| 4 | StockholdersEquity | 233,560,000 |
| 5 | NetIncome | 35,642,000 |
| 6 | ComprehensiveNetIncome | 35,133,000 |
| 7 | BaseVar | 588,678,000 |
| 8 | EconomicCapitalRatio | 1.51 |
Edgar->Model Mapping
Feature Distribution
Change over Time
